SCHEMBL10176679

SCHEMBL10176679

Cc1cc(OCCCO)ccc1C(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDIA6 Q15084 1/20 0.44
▸ TP53 P04637 2/20 0.43
▸ GAA P10253 1/20 0.43
▸ PDK2 Q15119 2/20 0.40
▸ NR1I2 O75469 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ DRD2 P14416 1/20 0.38
▸ DRD4 P21917 1/20 0.38
▸ DRD3 P35462 1/20 0.38
▸ MCL1 Q07820 1/20 0.38
▸ MAPK1 P28482 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ CYP1A2 P05177 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10176673 0.92 CYP3A4 (0.46) PDIA6TP53GAAPDK2NR1I2
SCHEMBL19504075 0.88 PDIA6 (0.46) PDIA6TP53GAASMN1; SMN2CYP3A4
SCHEMBL15187968 0.86 PDIA6 (0.46) PDIA6GAACYP3A4DRD2DRD4
SCHEMBL31216411 0.83 ALDH1A1 (0.51) PDIA6GAANR1I2SMN1; SMN2CYP1A2
SCHEMBL3480596 0.83 ALDH1A1 (0.51) PDIA6GAANR1I2SMN1; SMN2CYP1A2
SCHEMBL25946876 0.83 PTGS1 (0.43) PDIA6TP53GAAPDK2MAPK1
SCHEMBL19777391 0.83 PDIA6 (0.46) PDIA6SMN1; SMN2MAPK1NPC1RAB9A
SCHEMBL10176664 0.81 PDIA6 (0.41) PDIA6SMN1; SMN2DRD2DRD4DRD3
SCHEMBL10176661 0.81 KDM4E (0.51) PDIA6PDK2SMN1; SMN2KDM4EALDH1A1
SCHEMBL8225767 0.79 NQO1 (0.48) PDIA6TP53CYP3A4MEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119812-B2 Thiazolidinone derivative SBI BIOTECH CO., LTD. (JP) 2012-02-21 — — US disclosed
US-8119812-B2 Thiazolidinone derivative SBI BIOTECH CO., LTD. (JP) 2012-02-21 — — US disclosed
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE SBI BIOTECH CO., LTD. (JP) 2011-08-04 — — US disclosed
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE SBI BIOTECH CO., LTD. (JP) 2011-08-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE CDC7, CDK17, CDCA2 PDIA6 1224/4885TP53 578/4885GAA 2934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback